Cover Image
市場調查報告書

美國的傷口縫合設備市場未來展望

United States Wound Closure Devices Market Outlook to 2020

出版商 GlobalData 商品編碼 316770
出版日期 內容資訊 英文 155 Pages
訂單完成後即時交付
價格
Back to Top
美國的傷口縫合設備市場未來展望 United States Wound Closure Devices Market Outlook to 2020
出版日期: 2014年10月15日 內容資訊: 英文 155 Pages
簡介

本報告提供美國的傷口縫合設備市場現狀與未來發展預測相關分析,提供您整體市場規模(以金額·數量為準)的實際成果值·預測值,及個別產品的詳細趨勢,市場價格趨勢,市場佔有率(各流通管道·各企業),主要企業的概要與策略,最新的市場動靜(資本交易等)等調查。

第1章 目錄

第2章 簡介

  • 關於本報告內容
  • 傷口縫合設備的分類
  • 分析對象定義

第3章 美國的傷口縫合設備市場

  • 市場收益的實際成果值(以金額為準,過去9年份)
  • 市場收益的預測值(以金額為準,今後8年份)
  • 市場規模的實際成果值(以數量為準,過去9年份)
  • 市場規模的預測值(以數量為準,今後8年份)
    • 止血鉗:市場趨勢(以金額·數量為準,總計16年份)
    • 血管夾:市場趨勢(以金額·數量為準,總計16年份)
    • 外科用防粘黏薄膜:市場趨勢(以金額·數量為準,總計16年份)
    • 外科用縫合設備:市場趨勢(以金額·數量為準,總計16年份)
      • 手動式縫合設備
      • 電動式縫合設備
    • 組織黏合劑:市場趨勢(以金額·數量為準,總計16年份)
    • 組織密封膠:市場趨勢(以金額·數量為準,總計16年份)
      • 非合成密封膠
      • 纖維蛋白為基礎的·密封膠
  • 平均價格(總計16年份)
  • 各流通管道的市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第4章 主要企業

  • Johnson & Johnson
  • Covidien plc
  • Baxter International Inc.
  • Pfizer Inc.
  • 3M Health Care Ltd
  • Genzyme Corporation
  • Teleflex Incorporated
  • B. Braun Melsungen AG

第5章 現在正在開發(開發平台上)的傷口縫合設備

第6章 資本交易環境

  • 股票上市(1件)
  • 風險企業投資(全4件)

第7章 近幾年趨勢

  • 企業通訊(全5件)
  • 財務相關資訊(全18件)
  • 政府·公益相關資訊(全7件)
  • 其他重要的動向(1件)
  • 產品資訊(1件)
  • 策略·產業計畫資訊(全3件)

第8章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC0844DB

GlobalData's new report, "United States Wound Closure Devices Market Outlook to 2020", provides key market data on the United States Wound Closure Devices Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hemostats (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based and Collagen Based Hemostats), Tissue Adhesives (Cyanoacrylate Based and Other Cross-linkable Polymer Based Tissue Adhesives), Tissue Sealants (Synthetic Tissue Sealants and Non-Synthetic Tissue Sealants (Fibrin Based Tissue Sealants (Fibrin Based Tissue Sealants in Liquid Form and in Patch Form), Collagen Based Tissue Sealants and Protein Based Tissue Sealants)), Ligating Clips (Titanium and Polymer Ligating Clips), Surgical Stapling Devices (Powered Surgical Stapling Devices (Reusable Powered and Disposable Powered Surgical Stapling Devices), Manual Surgical Stapling Devices (Reusable Manual and Disposable Manual Surgical Stapling Devices)), Surgical Adhesion Barriers (Membrane and Gel Adhesion Barriers) and Wound Closure Strips.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Closure Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Wound Closure Devices market segments - Hemostats, Tissue Adhesives, Tissue Sealants, Ligating Clips, Surgical Stapling Devices, Surgical Adhesion Barriers and Wound Closure Strips.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Wound Closure Devices market.
  • Global corporate-level profiles of key companies operating within the United States Wound Closure Devices.
  • Key players covered include Johnson & Johnson, Baxter International Inc. and Pfizer Inc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Wound Closure Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Wound Closure Devices Market, United States

  • 3.1. Wound Closure Devices Market, United States, Revenue ($m), 2005-2013
  • 3.2. Wound Closure Devices Market, United States, Revenue ($m), 2013-2020
    • 3.2.1. Hemostats Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Ligating Clips Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.3. Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.4. Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2005-2013
      • 3.2.4.1. Manual Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2005-2013
      • 3.2.4.2. Powered Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.5. Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.6. Tissue Sealants Market, United States, Revenue ($m), by Segment, 2005-2013
      • 3.2.6.1. Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2005-2013
        • 3.2.6.1.1. Fibrin Based Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.7. Hemostats Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.8. Ligating Clips Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.9. Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.10. Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2013-2020
      • 3.2.10.1. Manual Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2013-2020
      • 3.2.10.2. Powered Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2013-2020
    • 3.2.11. Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.12. Tissue Sealants Market, United States, Revenue ($m), by Segment, 2013-2020
      • 3.2.12.1. Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2013-2020
        • 3.2.12.1.1. Fibrin Based Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2013-2020
    • 3.3. Wound Closure Devices Market, United States, Volume (Units), 2005-2013
    • 3.4. Wound Closure Devices Market, United States, Volume (Units), 2013-2020
      • 3.4.1. Hemostats Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.2. Ligating Clips Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.3. Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.4. Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2005-2013
        • 3.4.4.1. Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2005-2013
        • 3.4.4.2. Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2005-2013
      • 3.4.5. Tissue Adhesives Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.6. Tissue Sealants Market, United States, Volume (Units), by Segment, 2005-2013
        • 3.4.6.1. Non-Synthetic Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2005-2013
          • 3.4.6.1.1. Fibrin Based Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2005-2013
      • 3.4.7. Hemostats Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.8. Ligating Clips Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.9. Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.10. Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2013-2020
        • 3.4.10.1. Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2013-2020
        • 3.4.10.2. Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2013-2020
      • 3.4.11. Tissue Adhesives Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.12. Tissue Sealants Market, United States, Volume (Units), by Segment, 2013-2020
        • 3.4.12.1. Non-Synthetic Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2013-2020
        • 3.4.12.1.1. Fibrin Based Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2013-2020
  • 3.5. Wound Closure Devices Market, United States, Average Price ($), 2005-2020
  • 3.6. Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Wound Closure Devices Market, United States, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in United States, Wound Closure Devices Market

  • 4.1. Johnson & Johnson
    • 4.1.1. Company Overview
  • 4.2. Covidien plc
    • 4.2.1. Company Overview
  • 4.3. Baxter International Inc.
    • 4.3.1. Company Overview
  • 4.4. Pfizer Inc.
    • 4.4.1. Company Overview
  • 4.5. 3M Health Care Ltd
    • 4.5.1. Company Overview
  • 4.6. Genzyme Corporation
    • 4.6.1. Company Overview
  • 4.7. Teleflex Incorporated
    • 4.7.1. Company Overview
  • 4.8. B. Braun Melsungen AG
    • 4.8.1. Company Overview

5. Wound Closure Devices Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Equity Offerings
    • 6.1.1. Derma Sciences Completes Public Offering Of Shares For US$86.3 Million
    • 6.1.2. SafeStitch Medical Completes Private Placement Of Shares And Warrants For US$3 Million
  • 6.2. Venture Financing
    • 6.2.1. BioDerm to Raise USD4.8 Million in Venture Financing
    • 6.2.2. Surgimatix To Raise US$0.5 Million In Venture Financing
    • 6.2.3. MxBiodevices To Raise US$8 Million In Venture Financing
    • 6.2.4. MxBiodevices Raises US$0.2 Million In Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Apr 07, 2014: Cytomedix Announces Appointment of Andrew Cohen as Vice President of Marketing
    • 7.1.2. Mar 31, 2014: Cytomedix Announces Senior Management Appointments
    • 7.1.3. Mar 18, 2014: Theragenics Appoints Mark Kesti as Vice President of Sales for Galt Medical and NeedleTech Products
    • 7.1.4. Mar 01, 2014: Patient Satisfaction and Convenience Increased with Current Hereditary Angioedema Treatment Options, According to Study Findings
    • 7.1.5. Nov 04, 2013: BioDerm Appoints Jim Terpstra as National Sales Manager
  • 7.2. Financial Announcements
    • 7.2.1. Aug 14, 2014: Cytomedix Reports Second Quarter 2014 Financial Results
    • 7.2.2. Aug 07, 2014: Derma Sciences Reports Second Quarter Financial Results
    • 7.2.3. Jul 24, 2014: Bard Announces Second Quarter Results
    • 7.2.4. Jun 19, 2014: Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir FlexTouch
    • 7.2.5. May 15, 2014: Cytomedix Reports 2014 First Quarter Financial Results
    • 7.2.6. May 08, 2014: Derma Sciences Reports First Quarter Financial Results
    • 7.2.7. Apr 22, 2014: Bard Announces First Quarter Results
    • 7.2.8. Mar 31, 2014: Cytomedix Reports 2013 Fourth Quarter and Full Year Financial Results
    • 7.2.9. Mar 14, 2014: Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products
    • 7.2.10. Jan 30, 2014: Bard Announces Fourth Quarter Results
    • 7.2.11. Jan 16, 2014: Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance
    • 7.2.12. Dec 23, 2013: Titan Pharmaceuticals Receives Official Minutes From FDA Meeting on Probuphine New Drug Application
    • 7.2.13. Dec 11, 2013: Bard Declares Quarterly Dividend
    • 7.2.14. Nov 13, 2013: Derma Sciences Reports Third Quarter Financial Results
    • 7.2.15. Nov 12, 2013: Cytomedix Reports Third Quarter 2013 Financial Results
    • 7.2.16. Nov 06, 2013: Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 13th
    • 7.2.17. Oct 22, 2013: Bard Announces Third Quarter Results
    • 7.2.18. Oct 09, 2013: Bard Declares Quarterly Dividend
  • 7.3. Government and Public Interest
    • 7.3.1. Jan 06, 2014: Bard to Host Earnings Conference Call on January 30, 2014
    • 7.3.2. Dec 20, 2013: Bard to Present at J.P. Morgan Healthcare Conference
    • 7.3.3. Dec 04, 2013: Derma Sciences to Present at the Oppenheimer & Co. Inc. 24th Annual Healthcare Conference
    • 7.3.4. Nov 25, 2013: Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference
    • 7.3.5. Nov 20, 2013: Bard to Present at Piper Jaffray Healthcare Conference
    • 7.3.6. Nov 12, 2013: Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum
    • 7.3.7. Oct 29, 2013: Bard to Present at Credit Suisse Healthcare Conference
  • 7.4. Other Significant Developments
    • 7.4.1. Apr 16, 2014: Bard Declares Quarterly Dividend
  • 7.5. Product News
    • 7.5.1. Jul 21, 2014: US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
  • 7.6. Strategy And Business Planning
    • 7.6.1. Sep 30, 2014: CSL Behring Expands Manufacturing Facility in Kankakee, Illinois to Meet Patients Growing Needs
    • 7.6.2. Aug 27, 2014: Theragenics Opens Manufacturing Plant in Costa Rica
    • 7.6.3. Aug 20, 2014: Cytomedix Partners With Net Health to Expand CED Data Collection Capabilities to Approximately 400 Additional Wound Care Centers

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Hemostats Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Ligating Clips Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 5: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 6: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 7: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 8: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 9: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 10: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 11: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 12: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 13: Hemostats Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 14: Ligating Clips Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 15: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 16: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 17: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 18: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 19: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 20: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 21: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 22: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 23: Wound Closure Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Table 24: Wound Closure Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 25: Hemostats Market, United States, Volume (Units), Historic, 2005-2013
  • Table 26: Ligating Clips Market, United States, Volume (Units), Historic, 2005-2013
  • Table 27: Surgical Adhesion Barriers Market, United States, Volume (Units), Historic, 2005-2013
  • Table 28: Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Table 29: Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 30: Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 31: Tissue Adhesives Market, United States, Volume (Units), Historic, 2005-2013
  • Table 32: Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Table 33: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Table 34: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Table 35: Hemostats Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 36: Ligating Clips Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 37: Surgical Adhesion Barriers Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 38: Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 39: Manual Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 40: Powered Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 41: Tissue Adhesives Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 42: Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 43: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 44: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 45: Wound Closure Devices Market, United States, Average Price ($), Historic, 2005-2013
  • Table 46: Wound Closure Devices Market, United States, Average Price ($), Forecast, 2013-2020
  • Table 47: Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 48: Wound Closure Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 49: Wound Closure Devices Market Pipeline Products
  • Table 50: Derma Sciences Completes Public Offering Of Shares For US$86.3 Million
  • Table 51: SafeStitch Medical Completes Private Placement Of Shares And Warrants For US$3 Million
  • Table 52: BioDerm to Raise USD4.8 Million in Venture Financing
  • Table 53: Surgimatix To Raise US$0.5 Million In Venture Financing
  • Table 54: MxBiodevices To Raise US$8 Million In Venture Financing
  • Table 55: MxBiodevices Raises US$0.2 Million In Venture Financing
  • Table 56: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Hemostats Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Ligating Clips Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 5: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 6: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 7: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 8: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 9: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 10: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 11: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 12: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 13: Hemostats Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 14: Ligating Clips Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 15: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 16: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 17: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 18: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 19: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 20: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 21: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 22: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 23: Wound Closure Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 24: Wound Closure Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 25: Hemostats Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 26: Ligating Clips Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 27: Surgical Adhesion Barriers Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 28: Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 29: Manual Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 30: Powered Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 31: Tissue Adhesives Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 32: Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 33: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 34: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 35: Hemostats Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 36: Ligating Clips Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 37: Surgical Adhesion Barriers Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 38: Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 39: Manual Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 40: Powered Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 41: Tissue Adhesives Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 42: Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 43: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 44: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 45: Wound Closure Devices Market, United States, Company Share (%), 2013
  • Figure 46: GlobalData Epidemiology-Based Forecasting Model
  • Figure 47: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 48: Primary Interviews by Participant Type (%)
Back to Top